您的位置: 首页 > 农业专利 > 详情页

METHODES DE TRAITEMENT DU LYMPHOME DIFFUS A GRANDES CELLULES B ET UTILISATION DE BIOMARQUEURS COMME PREDICTEURS DE SENSIBILITE A DES MEDICAMENTS
专利权人:
CELGENE CORPORATION
发明人:
TROTTER, MATTHEW WILLIAM BURNELL,RISUENO-PEREZ, ALBERTO,POURDEHNAD, MICHAEL,GANDHI, ANITA,HAGNER, PATRICK
申请号:
CA2999179
公开号:
CA2999179A1
申请日:
2016.09.22
申请国别(地区):
CA
年份:
2017
代理人:
摘要:
In one aspect, provided herein are methods for predicting the responsiveness of DLBCL patients to treatment with lenolidomide or Compound A; or a stereoisomer thereof; or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate thereof; or a polymorph thereof utilizing biomarkers or classfiers that correlate with responsiveness to one of these drugs. In another aspect, provided herein are methods for treating a DLBCL patient determined to be responsive to treatment with lenolidomide or Compound A; or a stereoisomer thereof; or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate thereof; or a polymorph thereof utilizing biomarkers or classifiers (or output thereof) that correlate with responsiveness to one of these drugs.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充